Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000081607 | SCV000113538 | benign | not specified | 2013-05-28 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000345245 | SCV000467215 | benign | Cortical dysplasia-focal epilepsy syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000392429 | SCV000467216 | benign | Pitt-Hopkins-like syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001719842 | SCV000714948 | benign | not provided | 2019-11-19 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000345245 | SCV002405135 | benign | Cortical dysplasia-focal epilepsy syndrome | 2025-02-04 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002345397 | SCV002651096 | benign | Inborn genetic diseases | 2016-05-31 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |